Yuhan Corporation (KRX:000100)

South Korea flag South Korea · Delayed Price · Currency is KRW
91,600
-1,600 (-1.72%)
Last updated: Apr 30, 2026, 3:00 PM KST
Market Cap6.80T -17.2%
Revenue (ttm)2.19T +5.7%
Net Income194.08B +174.6%
EPS2,599.51 +175.6%
Shares Out74.44M
PE Ratio35.24
Forward PE42.46
Dividend500.00 (0.54%)
Ex-Dividend DateFeb 26, 2026
Volume271,243
Average Volume179,911
Open93,200
Previous Close93,200
Day's Range91,600 - 93,400
52-Week Range90,900 - 136,400
Beta0.46
RSI37.92
Earnings DateMay 15, 2026

About Yuhan

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperl... [Read more]

Sector Healthcare
Founded 1926
Employees 2,067
Stock Exchange Korea Stock Exchange
Ticker Symbol 000100
Full Company Profile

Financial Performance

In 2025, Yuhan's revenue was 2.19 trillion, an increase of 5.75% compared to the previous year's 2.07 trillion. Earnings were 194.08 billion, an increase of 174.56%.

Financial Statements